Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-01-03
2006-01-03
Qazi, Sabiha N. (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
C552S653000
Reexamination Certificate
active
06982257
ABSTRACT:
Provided are 1,25-dihydroxy-2-methylvitamin D3 derivatives expressed by the general formula (I),[wherein each of R1and R2is independently a hydrogen atom or a tri(C1to C7alkyl)silyl group; herein configurations of asymmetric carbons at the 1-, 2- and 3-positions are each independently α-configuration or β-configuration] and their production methods.The compound is useful as a treating agent for osteoporosis, rickets, hyperthyroidism, etc.
REFERENCES:
patent: 5389622 (1995-02-01), Posner et al.
patent: 5552392 (1996-09-01), DeLuca et al.
patent: 5585369 (1996-12-01), DeLuca et al.
patent: 5877168 (1999-03-01), Miyamoto et al.
patent: 6124276 (2000-09-01), Miyamoto et al.
patent: 6-41059 (1994-02-01), None
patent: WO 95/17363 (1995-06-01), None
S. Nayeri et al; High-Affinity Nuclear Receptor Binding of 20-epi Analogues of 1,25-Dihydroxyvitamin D3 Correlates Well with Gene Activation; Feb. 2, 1996; pp. 325-333, J. of Cellular Biochemistry 62:325-333 (1996).
G. Posner et al; 2-Fluoroalkyl A-Ring Analogs of 1,25-Dihydroxyvitamin D3. Stereocontrolled Total Synthesis Via Intramolecular and Intermolecular Diels-Alder Cycloadditions, Preliminary Biological Testing; 1995; pp. 4617-4628; vol. 60; vol. 60, No. 14, J. Org. Chemistry.
Kobayashi et al; 116th (1996) Congress of The Pharmaceutical Society of Japan, Abstract 3, 88.
Maki et al; 116th (1996) Congress of the Pharmaceutical Society of Japan, Abstract 2,9.
Katsuhiro Konno, et al.: “A Novel and Practical Route to A-Ring Enyne Synthon for 1α, 25-Dihydroxyvitamin D3Analogs: Synthesis of A-Ring Diastereomers of 1α, 25-Dihydroxyvitamin D3.” Bioorganic & Medicinal Chemistry Letters, vol. 8, No. 2, Jan. 20, 1998, p. 151-156. XP004136835.
Fujishima Toshie
Konno Katsuhiro
Takayama Hiroaki
Qazi Sabiha N.
Teijin Limited
LandOfFree
Vitamin D3 derivative and its production method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D3 derivative and its production method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D3 derivative and its production method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524698